Drug Patents owned by Sk Life

1. Drug name - XCOPRI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7598279 SK LIFE Neurotherapeutic azole compounds
Oct, 2027

(5 years from now)

CN101228138B SK LIFE Nerve Healing Pyrrole Compound
Apr, 2026

(3 years from now)

CN101228138A SK LIFE Neurotherapeutic Azole Compounds
Apr, 2026

(3 years from now)

IN286726B SK LIFE Neurotherapeutic Azole Compounds
Apr, 2026

(3 years from now)

IN200708902P1 SK LIFE Neurother Apeutic Azole Compounds
Apr, 2026

(3 years from now)

EP1879873A4 SK LIFE Neurotherapeutic Azole Compounds
Apr, 2026

(3 years from now)

EP1879873B1 SK LIFE Neurotherapeutic Azole Compounds
Apr, 2026

(3 years from now)

EP1879873A1 SK LIFE Neurotherapeutic Azole Compounds
Apr, 2026

(3 years from now)

Drugs and Companies using CENOBAMATE ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
12.5MG TABLET;ORAL Prescription
25MG TABLET;ORAL Prescription
50MG TABLET;ORAL Prescription
100MG TABLET;ORAL Prescription
150MG TABLET;ORAL Prescription
200MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.